Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 14, 2010

View Archived Issues

PBT-434 prevents nigral cell death in models of Parkinson's disease

Piramal Life Sciences describes preclinical pharmacology of new insulin sensitizer P-1738

Studies further characterize HIV integrase inhibitor S/GSK-1349572

Multiple studies describe preclinical profile of antibacterial polypeptide NZ-17074

Helix BioPharma completes GLP toxicology studies of L-DOS-47

Roskamp Institute to begin trials of RCP-006 for treatment of Alzheimer's disease

Genmab and Lundbeck to collaborate on human antibodies for CNS disorders

Merck Frosst discovers novel acyl-CoA desaturase inhibitors

Bayer Schering Pharma discovers vasopressin receptor inhibitors

E.U. concerned member states reach positive agreement for approval of Vimovo

Novel GlyT-1 inhibitors synthesized at sanofi-aventis

ArQule and Daiichi Sankyo expand new kinase inhibitor discovery collaboration

Boehringer Ingelheim discloses new FADK 1 inhibitors

Cell Cure Neurosciences receives investments to develop stem cell treatments

SEPS Pharma patents new antifungal fluconazole derivatives

Tesetaxel receives EMA orphan drug status for gastric cancer

EMA approves Twynsta single pill combination for high blood pressure

Pharmalink obtains FDA orphan drug designation for PL-56

Boehringer Ingelheim discontinues flibanserin development

Antisoma provides update in interim management statement

Alexza receives FDA complete response letter for AZ-004 NDA

Genentech begins phase II vismodegib trial in operable basal cell carcinoma

ESMO and Thomson Reuters collaborate on oncology web portal

Encouraging results reported for phase IIb trial of A-3309 in chronic idiopathic constipation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...